﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2024v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2025-08-21T15:03:22-04:00</ReturnTs>
    <TaxPeriodEndDt>2024-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>471953768</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>KPGCPA FINANCIAL SERVICES INC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>1900 CAMDEN AVENUE SUITE 201-A</AddressLine1Txt>
        <CityNm>SAN JOSE</CityNm>
        <StateAbbreviationCd>CA</StateAbbreviationCd>
        <ZIPCd>95124</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990EZ</ReturnTypeCd>
    <TaxPeriodBeginDt>2024-09-24</TaxPeriodBeginDt>
    <Filer>
      <EIN>995074660</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>THE ASSOCIATION OF MULTISITE RESEAR</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>CH CORPORATIONS (AMRC)</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>ASSO</BusinessNameControlTxt>
      <PhoneNum>4079881197</PhoneNum>
      <USAddress>
        <AddressLine1Txt>615 CRESCENT EXECUTIVE CRT STE 120</AddressLine1Txt>
        <CityNm>LAKE MARY</CityNm>
        <StateAbbreviationCd>FL</StateAbbreviationCd>
        <ZIPCd>32746</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>JAMES KREMIDAS</PersonNm>
      <PersonTitleTxt>EXECUTIVE DIRECTOR</PersonTitleTxt>
      <PhoneNum>8025798552</PhoneNum>
      <SignatureDt>2025-08-14</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>true</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>KOSHY PGEORGE CPA</PreparerPersonNm>
      <PTIN>P00957032</PTIN>
      <PhoneNum>4085583619</PhoneNum>
      <PreparationDt>2025-08-21</PreparationDt>
      <SelfEmployedInd>X</SelfEmployedInd>
    </PreparerPersonGrp>
    <TaxYr>2024</TaxYr>
    <BuildTS>2025-03-06 01:10:19Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="3">
    <IRS990EZ documentId="RetDoc2" referenceDocumentId="RetDoc3">
      <AddressChangeInd>X</AddressChangeInd>
      <InitialReturnInd>X</InitialReturnInd>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <WebsiteAddressTxt>HTTPS://AMRC.ORG</WebsiteAddressTxt>
      <Organization501cInd organization501cTypeTxt="6">X</Organization501cInd>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <GrossReceiptsAmt>87500</GrossReceiptsAmt>
      <InfoInScheduleOPartIInd>X</InfoInScheduleOPartIInd>
      <ContributionsGiftsGrantsEtcAmt>87500</ContributionsGiftsGrantsEtcAmt>
      <TotalRevenueAmt>87500</TotalRevenueAmt>
      <SalariesOtherCompEmplBnftAmt>23175</SalariesOtherCompEmplBnftAmt>
      <FeesAndOtherPymtToIndCntrctAmt>23639</FeesAndOtherPymtToIndCntrctAmt>
      <OtherExpensesTotalAmt>14868</OtherExpensesTotalAmt>
      <TotalExpensesAmt>61682</TotalExpensesAmt>
      <ExcessOrDeficitForYearAmt>25818</ExcessOrDeficitForYearAmt>
      <NetAssetsOrFundBalancesEOYAmt>25818</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIInd>X</InfoInScheduleOPartIIInd>
      <CashSavingsAndInvestmentsGrp>
        <EOYAmt>41444</EOYAmt>
      </CashSavingsAndInvestmentsGrp>
      <OtherAssetsTotalDetail>
        <EOYAmt>9403</EOYAmt>
      </OtherAssetsTotalDetail>
      <Form990TotalAssetsGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>50847</EOYAmt>
      </Form990TotalAssetsGrp>
      <SumOfTotalLiabilitiesGrp>
        <EOYAmt>25029</EOYAmt>
      </SumOfTotalLiabilitiesGrp>
      <NetAssetsOrFundBalancesGrp>
        <BOYAmt>0</BOYAmt>
        <EOYAmt>25818</EOYAmt>
      </NetAssetsOrFundBalancesGrp>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <PrimaryExemptPurposeTxt>TO SERVE AS A DEDICATED ADVOCATE AND INTERFACE BETWEEN MULTISITE CLINICAL RESEARCH CORPORATIONS (MCRCS), SPONSORS, CROS, REGULATORS AND PATIENTS, ENSURING THAT THE UNIQUE ADVANTAGES OF MULTISITE ORGANIZATIONS ARE UNDERSTOOD AND LEVERAGED TO ADVANCE CLINICAL RESEARCH.</PrimaryExemptPurposeTxt>
      <ProgramSrvcAccomplishmentGrp>
        <DescriptionProgramSrvcAccomTxt>TO SERVE AS A DEDICATED ADVOCATE AND INTERFACE BETWEEN MULTISITE CLINICAL RESEARCH CORPORATIONS (MCRCS), SPONSORS, CROS, REGULATORS AND PATIENTS, ENSURING THAT THE UNIQUE ADVANTAGES OF MULTISITE ORGANIZATIONS ARE UNDERSTOOD AND LEVERAGED TO ADVANCE CLINICAL RESEARCH.</DescriptionProgramSrvcAccomTxt>
      </ProgramSrvcAccomplishmentGrp>
      <ProgramSrvcAccomplishmentGrp>
        <DescriptionProgramSrvcAccomTxt>TO SERVE AS A DEDICATED ADVOCATE AND INTERFACE BETWEEN MULTISITE CLINICAL RESEARCH CORPORATIONS (MCRCS), SPONSORS, CROS, REGULATORS AND PATIENTS, ENSURING THAT THE UNIQUE ADVANTAGES OF MULTISITE ORGANIZATIONS ARE UNDERSTOOD AND LEVERAGED TO ADVANCE CLINICAL RESEARCH.</DescriptionProgramSrvcAccomTxt>
      </ProgramSrvcAccomplishmentGrp>
      <OfficerDirectorTrusteeEmplGrp>
        <PersonNm>CARLOS ORANTES</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHrsPerWkDevotedToPosRt>14.00</AverageHrsPerWkDevotedToPosRt>
        <CompensationAmt>0</CompensationAmt>
      </OfficerDirectorTrusteeEmplGrp>
      <OfficerDirectorTrusteeEmplGrp>
        <PersonNm>JENNIFER BYRNE</PersonNm>
        <TitleTxt>VICE CHAIR</TitleTxt>
        <AverageHrsPerWkDevotedToPosRt>14.00</AverageHrsPerWkDevotedToPosRt>
        <CompensationAmt>0</CompensationAmt>
      </OfficerDirectorTrusteeEmplGrp>
      <OfficerDirectorTrusteeEmplGrp>
        <PersonNm>E B MCLINDON</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHrsPerWkDevotedToPosRt>14.00</AverageHrsPerWkDevotedToPosRt>
        <CompensationAmt>0</CompensationAmt>
      </OfficerDirectorTrusteeEmplGrp>
      <OfficerDirectorTrusteeEmplGrp>
        <PersonNm>WILLIAM SMITH</PersonNm>
        <TitleTxt>CHAIR</TitleTxt>
        <AverageHrsPerWkDevotedToPosRt>14.00</AverageHrsPerWkDevotedToPosRt>
        <CompensationAmt>0</CompensationAmt>
      </OfficerDirectorTrusteeEmplGrp>
      <OfficerDirectorTrusteeEmplGrp>
        <PersonNm>PAUL EVANS</PersonNm>
        <TitleTxt>VICE CHAIR</TitleTxt>
        <AverageHrsPerWkDevotedToPosRt>14.00</AverageHrsPerWkDevotedToPosRt>
        <CompensationAmt>0</CompensationAmt>
      </OfficerDirectorTrusteeEmplGrp>
      <OfficerDirectorTrusteeEmplGrp>
        <PersonNm>JAMES KREMIDAS</PersonNm>
        <TitleTxt>EXECUTIVE DI</TitleTxt>
        <AverageHrsPerWkDevotedToPosRt>8.00</AverageHrsPerWkDevotedToPosRt>
        <CompensationAmt>23175</CompensationAmt>
      </OfficerDirectorTrusteeEmplGrp>
      <ActivitiesNotPreviouslyRptInd>false</ActivitiesNotPreviouslyRptInd>
      <ChgMadeToOrgnzngDocNotRptInd>false</ChgMadeToOrgnzngDocNotRptInd>
      <OrganizationHadUBIInd>false</OrganizationHadUBIInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <OrganizationDissolvedEtcInd>false</OrganizationDissolvedEtcInd>
      <Form1120PolFiledInd>false</Form1120PolFiledInd>
      <MadeLoansToFromOfficersInd>false</MadeLoansToFromOfficersInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <BooksInCareOfDetail>
        <PersonNm>WILLIAM FURNESS</PersonNm>
        <USAddress>
          <AddressLine1Txt>172 CAROLYN CIRCLE</AddressLine1Txt>
          <CityNm>MARSHFIELD</CityNm>
          <StateAbbreviationCd>MA</StateAbbreviationCd>
          <ZIPCd>02050</ZIPCd>
        </USAddress>
        <PhoneNum>8022810482</PhoneNum>
      </BooksInCareOfDetail>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <DonorAdvisedFndsInd>false</DonorAdvisedFndsInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <TanningServicesProvidedInd>false</TanningServicesProvidedInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TransactionWithControlEntInd>false</TransactionWithControlEntInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
    </IRS990EZ>
    <IRS990ScheduleB documentId="RetDoc1">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleO documentId="RetDoc3">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990-EZ, PART I, LINE 16</FormAndLineReferenceDesc>
        <ExplanationTxt>EXPENSES 13,915 953 TOTAL 14,868</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990-EZ, PART II, LINE 24</FormAndLineReferenceDesc>
        <ExplanationTxt>ACCOUNTS RECEIVABLE 0 6,250 PREPAID EXPENSES AND DEFERRED CHARGES 0 3,153 TOTAL 0 9,403</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990-EZ, PART II, LINE 26</FormAndLineReferenceDesc>
        <ExplanationTxt>ACCOUNTS PAYABLE AND ACCRUED EXPENSES 0 21,717 PREPAID MEMBERSHIP 0 3,312</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990-EZ, PART III</FormAndLineReferenceDesc>
        <ExplanationTxt>TO SERVE AS A DEDICATED ADVOCATE AND INTERFACE BETWEEN MULTISITE CLINICAL RESEARCH CORPORATIONS (MCRCS), SPONSORS, CROS, REGULATORS AND PATIENTS, ENSURING THAT THE UNIQUE ADVANTAGES OF MULTISITE ORGANIZATIONS ARE UNDERSTOOD AND LEVERAGED TO ADVANCE CLINICAL RESEARCH.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990-EZ, PART III, LINE 28</FormAndLineReferenceDesc>
        <ExplanationTxt>TO SERVE AS A DEDICATED ADVOCATE AND INTERFACE BETWEEN MULTISITE CLINICAL RESEARCH CORPORATIONS (MCRCS), SPONSORS, CROS, REGULATORS AND PATIENTS, ENSURING THAT THE UNIQUE ADVANTAGES OF MULTISITE ORGANIZATIONS ARE UNDERSTOOD AND LEVERAGED TO ADVANCE CLINICAL RESEARCH.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990-EZ, PART III, LINE 31</FormAndLineReferenceDesc>
        <ExplanationTxt>TO SERVE AS A DEDICATED ADVOCATE AND INTERFACE BETWEEN MULTISITE CLINICAL RESEARCH CORPORATIONS (MCRCS), SPONSORS, CROS, REGULATORS AND PATIENTS, ENSURING THAT THE UNIQUE ADVANTAGES OF MULTISITE ORGANIZATIONS ARE UNDERSTOOD AND LEVERAGED TO ADVANCE CLINICAL RESEARCH.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>